See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A nerve pain drug is being overprescribed to people living in refugee ...

Pfizer, looking to protect billions in Lyrica sales, has been gunning for a 6-month pediatric exclusivity extension for its top drug. And on Tuesday, the FDA came through in favor of the drugmaker.

Pfizer’s Lyrica leads drug sales for the company--but it’s also doing big things for another of the med’s developers. Royalties on the nerve pain and seizure med have powered the endowment at ...

The widely prescribed pain drug pregabalin (brand name: Lyrica) may be no better than a placebo when it comes to treating the back and leg pain known as sciatica, a new clinical trial suggests. The ...